CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | −90,000 | 0 | ||
| 2021-12-07 | Claiborne Cary J Chief Operating Officer | Grant or award · Stock options | +130,000 | 130,000 | ||
| 2021-11-30 | Stilley William B. III Chief Executive Officer | Purchase | +10,600 | $2.75 | $29K | 937,646 |
| 2021-11-29 | Stilley William B. III Chief Executive Officer | Purchase | +10,000 | $2.59 | $26K | 927,046 |
| 2021-11-26 | Newman James W. Jr. Director | Purchase | +10,000 | $2.85 | $29K | 34,475 |
| 2021-11-02 | Claiborne Cary J Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2021-10-04 | Johnson Bankole A. Chief Medical Officer | Sale | −200,000 | 148,246 | ||
| 2021-10-04 | Johnson Bankole A. Chief Medical Officer | Other disposition · Warrant | −150,000 | 39,714 | ||
| 2021-04-06 | Johnson Bankole A. Chief Medical Officer | Sale | −150,000 | $2.50 | $375K | 548,336 |
| 2021-02-08 | Truluck Joseph Chief Financial Officer | Grant or award · Employee Stock Option | +125,000 | 125,000 | ||
| 2021-02-08 | Stilley William B. III Chief Executive Officer | Grant or award · Employee Stock Option | +250,000 | 250,000 | ||
| 2021-02-08 | Schuyler Kevin Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-02-08 | Newman James W. Jr. Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-02-08 | Goodman Tony Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-02-08 | Gilliland Robertson H. Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-02-08 | Anderson J. Kermit Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-01-26 | Stilley William B. III Chief Executive Officer | Grant or award | +201,109 | 917,046 | ||
| 2021-01-26 | Newman James W. Jr. Director | Grant or award | +1,187 | 14,475 | ||
| 2021-01-26 | Newman James W. Jr. Director | Grant or award | +2,544 | 152,963 | ||
| 2020-11-23 | Schuyler Kevin Director | Gift · Warrant to purchase common stock | +1,010 | 1,010 |
Page 5 of 10 · 190 trades